<DOC>
	<DOCNO>NCT00641758</DOCNO>
	<brief_summary>Pycnogenol® proprietary bark extract French maritime pine tree ( Pinus pinaster ssp . atlantica ) . Pycnogenol® prevent pathologic symptom chronic inflammation increase platelet aggregation , risk factor cardiovascular disease . The endothelium increasingly recognize target ( vascular remodelling occur response injury result atherosclerosis ) , also mediator pathogenesis atherosclerosis . Indeed , endothelial cell play important regulatory role cardiovascular system expression numerous molecule release mediator nitric oxide ( NO ) , superoxide endothelin-1 ( ET-1 ) . Data animal study , well human study indicate Pycnogenol may improve endothelial function , powerful surrogate clinical prognosis .</brief_summary>
	<brief_title>Pycnogenol Endothelial Function Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Pycnogenols</mesh_term>
	<criteria>History coronary artery disease ( documented coronary angiogram , nuclear imaging , positive stress test ) Stable cardiovascular medication least 1 month Age ≥ 18 year age time sign informed consent Informed consent participation study Myocardial infarction , unstable angina , stroke ( within 3 month randomization ) Thoracic cardiac surgery and/or coronary intervention/revascularisation procedure ( within 3 month randomization ) Uncontrolled symptomatic congestive heart failure ( NHYA &gt; II ) last 4 week prior study Renal insufficiency ( Creatinine Clearance &lt; 50ml/min ) Ventricular tachyarrhythmias Poorly control hypertension , define rest blood pressure ≥ 160/100 mmHg Symptomatic hypotension Obstructive cardiomyopathy , active myocarditis , constrictive pericarditis , untreated hypothyroidism hyperthyroidism adrenal insufficiency Severe uncorrected valvular disease leave ventricular outflow obstruction , , opinion investigator , require surgery Long act nitrate Oral intravenous steroid therapy Insulin dependent diabetes mellitus Recipient major organ transplant ( eg , lung , liver , heart ) renal replacement therapy Malignancy ( unless heal remission &gt; 5 year ) Anaemia ( Hb &lt; 10g/dl ) Known human immunodeficiency virus ( HIV ) positive active virus hepatitis Alanine transaminase ( ALT ) aspartate transaminase ( AST ) &gt; 3 time upper limit normal range Known hypersensitivity Pycnogenol® Alcohol , nicotine abuse illicit drug abuse Pregnancy breastfeeding , woman child bear potential without adequate contraception Disease systemic inflammation ( e.g . rheumatoid arthritis , M. Crohn ) Participation another study within last month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>Nitric oxide</keyword>
</DOC>